158 related articles for article (PubMed ID: 11844819)
1. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.
Ferrandina G; Lauriola L; Distefano MG; Zannoni GF; Gessi M; Legge F; Maggiano N; Mancuso S; Capelli A; Scambia G; Ranelletti FO
J Clin Oncol; 2002 Feb; 20(4):973-81. PubMed ID: 11844819
[TBL] [Abstract][Full Text] [Related]
2. Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
Distefano M; Ferrandina G; Smaniotto D; Margariti AP; Zannoni G; Macchia G; Manfredi R; Mangiacotti MG; Cellini N; Scambia G
Oncology; 2004; 67(2):103-11. PubMed ID: 15539913
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer.
Ferrandina G; Ranelletti FO; Legge F; Gessi M; Salutari V; Distefano MG; Lauriola L; Zannoni GF; Martinelli E; Scambia G
Clin Cancer Res; 2004 May; 10(9):3117-23. PubMed ID: 15131052
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery.
Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Poerio A; Zannoni GF; Smaniotto D; Margariti PA; Macchia G; Scambia G
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):21-7. PubMed ID: 12504032
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy.
Nagai N; Tian X; Mukai K; Hirata E; Kusuda T; Shiroyama Y; Shigemasa K; Ohama K
Int J Mol Med; 2003 Nov; 12(5):709-14. PubMed ID: 14532998
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
[TBL] [Abstract][Full Text] [Related]
8. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
9. Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.
Ferrandina G; Lauriola L; Zannoni GF; Fagotti A; Fanfani F; Legge F; Maggiano N; Gessi M; Mancuso S; Ranelletti FO; Scambia G
Ann Oncol; 2002 Aug; 13(8):1205-11. PubMed ID: 12181243
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
Ferrandina G; Ranelletti FO; Lauriola L; Fanfani F; Legge F; Mottolese M; Nicotra MR; Natali PG; Zakut VH; Scambia G
Gynecol Oncol; 2002 May; 85(2):305-10. PubMed ID: 11972392
[TBL] [Abstract][Full Text] [Related]
11. Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival.
Kim GE; Kim YB; Cho NH; Chung HC; Pyo HR; Lee JD; Park TK; Koom WS; Chun M; Suh CO
Clin Cancer Res; 2004 Feb; 10(4):1366-74. PubMed ID: 14977838
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer.
Ferrandina G; Ranelletti FO; Lauriola L; Zannoni GF; Legge F; Gessi M; Salutari V; Scambia G
Oncol Rep; 2003; 10(6):1799-804. PubMed ID: 14534699
[TBL] [Abstract][Full Text] [Related]
13. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications.
Ferrandina G; Lauriola L; Zannoni GF; Distefano MG; Legge F; Salutari V; Gessi M; Maggiano N; Scambia G; Ranelletti FO
Br J Cancer; 2002 Nov; 87(10):1145-52. PubMed ID: 12402155
[TBL] [Abstract][Full Text] [Related]
15. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
[TBL] [Abstract][Full Text] [Related]
16. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions.
Ferrandina G; Ranelletti FO; Salutari V; Gessi M; Legge F; Zannoni GF; Scambia G; Lauriola L
Gynecol Oncol; 2004 Feb; 92(2):537-44. PubMed ID: 14766245
[TBL] [Abstract][Full Text] [Related]
18. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
Cho EI; Kowalski DP; Sasaki CT; Haffty BG
Laryngoscope; 2004 Nov; 114(11):2001-8. PubMed ID: 15510031
[TBL] [Abstract][Full Text] [Related]
19. Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Ferrandina G; Distefano M; Smaniotto D; Morganti A; Paglia A; Macchia G; Corvari B; Lorusso D; Scambia G
Gynecol Oncol; 2006 Nov; 103(2):500-5. PubMed ID: 16677692
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G
J Clin Oncol; 1994 Nov; 12(11):2309-16. PubMed ID: 7964945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
